- Filed
- Feb 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 11, 2026 | 109.87M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 109.6M sh |
| Shares Diluted restated | Q1 2026 · Dec 31, 2024 | 109.41M sh |
| Capex | Q1 2026 · Dec 31, 2025 | $4K |
| Capex | Q1 2026 · Dec 31, 2024 | $1K |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$1.19M |
| Operating Cash Flow | Q1 2026 · Dec 31, 2024 | −$1.12M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $49.97M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $50.01M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $83.64M |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | $84.21M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.54M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $7.69M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.97M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $9.99M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $29.48M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $31.68M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $58.94M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $60M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | −$0.01 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $7.71M |
| Sga Expense restated | Q1 2026 · Dec 31, 2024 | $8.44M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$150K |
| Net Income | Q1 2026 · Dec 31, 2024 | −$692K |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$409K |
| Operating Income restated | Q1 2026 · Dec 31, 2024 | −$773K |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $7.41M |
| Gross Profit restated | Q1 2026 · Dec 31, 2024 | $7.93M |
| Cost Of Revenue | Q1 2026 · Dec 31, 2025 | $13.11M |
| Cost Of Revenue restated | Q1 2026 · Dec 31, 2024 | $16.1M |
| Revenue | Q1 2026 · Dec 31, 2025 | $20.52M |
| Revenue restated | Q1 2026 · Dec 31, 2024 | $24.03M |